Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Other Operating Expenses (2016 - 2025)

Cosmos Health's Other Operating Expenses history spans 13 years, with the latest figure at -$13.1 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at -$13.1 million for Q4 2025, down 175.22% from a year ago — trailing twelve months through Dec 2025 was -$7.1 million (down 3753.15% YoY), and the annual figure for FY2025 was -$7.6 million, down 4727.42%.
  • Other Operating Expenses for Q4 2025 was -$13.1 million at Cosmos Health, down from $2.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.4 million in Q3 2025 to a low of -$13.1 million in Q4 2025.
  • The 5-year median for Other Operating Expenses is $1.2 million (2022), against an average of -$1914.2.
  • The sharpest move saw Other Operating Expenses plummeted 1458.61% in 2021, then soared 443985.08% in 2023.
  • Year by year, Other Operating Expenses stood at $251221.0 in 2021, then soared by 266.51% to $920741.0 in 2022, then soared by 87.04% to $1.7 million in 2023, then crashed by 376.53% to -$4.8 million in 2024, then plummeted by 175.22% to -$13.1 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$13.1 million, $2.4 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.